Strategic Overview
Brightest Bio develops PF-LAM, a urine-based TB test for diagnosis in HIV+ populations.
Innovation Portfolio
PF-LAM
Point-of-care lateral flow assay for urinary LAM detection optimized for HIV-associated TB diagnosis. Simple visual readout with minimal training required.
Urine-LAM
Urine
Key Milestones
PF-LAM urine-based test
71% sensitivity in HIV+ patients
60-minute turnaround
Late-stage development
Affordable <$4 per test